Action ISKJ HUMAN STEM CELLS INSTITUTE
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Human Stem Cells Institute

Actions

ISKJ

RU000A0JNAB6

Cours en clôture Moscow Micex - RTS
Autres places de cotation
 00:00:00 08/07/2022 		Varia. 5j. Varia. 1 janv.
59,54 RUB +1,43 % Graphique intraday de Human Stem Cells Institute -.--% -.--%
26/04 Artgen Biotech PJSC publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Artgen Biotech PJSC publie ses résultats pour le semestre clos le 30 juin 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2023
Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2023
Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Full Year Ended December 31, 2022
GENETICO PJSC has completed an IPO in the amount of RUB 178.8 million.
GENETICO PJSC has filed an IPO.
Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Half Year Ended June 30, 2022
Public Joint-Stock Company "Human Stem Cells Institute" announced that it has received RUB 611.63608 million in funding from PJSC International Medical Center Processings and Kriokhraneniya of Biomaterialy
Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Full Year Ended December 31, 2021
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company acquired 6.93% stake in Public Joint-Stock Company "Human Stem Cells Institute".
GENETICO LLC announced that it expects to receive RUB 228.948921 million in funding from Public Joint-Stock Company "Human Stem Cells Institute"
Public Joint-Stock Company Human Stem Cells Institute Reports Earnings Results for the Half Year Ended June 30, 2021
Public Joint-Stock Company "Human Stem Cells Institute" announced that it expects to receive funding from PJSC International Medical Center Processings and Kriokhraneniya of Biomaterialy
Public Joint-Stock Company "Human Stem Cells Institute" announced that it has received RUB 400 million in funding from Limited Liability Company "IceGen 2"
Public Joint-Stock Company Human Stem Cells Institute Reports Earnings Results for the Full Year Ended December 31, 2020
Public Joint-Stock Company "Human Stem Cells Institute" announced that it has received funding from Limited Liability Company "IceGen 2"
Public Joint-Stock Company "Human Stem Cells Institute" and Artur Isaev acquired 17.79% interest in GENETICO LLC from RVC Biopharmaceutical Investments, Limited liability Company, managed by RVC, Investment Arm.
Public Joint-Stock Company "Human Stem Cells Institute" announced that it expects to receive funding from Limited Liability Company "IceGen 2"
An unknown buyer acquired 15% stake in Human Stem Cells Institute PJSC from Mezhdunarodnogo Meditsinskogo Centra Obrabotki i Kriokhraneniya Biomaterialy.
Human Stem Cells Institute PAO Announces Dividend
Artur Isayev acquired 16.68% stake in Human Stem Cells Institute PJSC.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ISKJ
  4. Actualités Human Stem Cells Institute
  5. Autres langues